DTL
LXRX icon

Dynamic Technology Lab’s Lexicon Pharmaceuticals LXRX Stock Holding History

Dynamic Technology Lab’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,338
Closed -$18K – 1182
2024
Q3 		$18K Buy
+11,338
New +$20.2K ﹤0.01% 967
2021
Q2 		– Sell
-19,084
Closed -$112K – 1346
2021
Q1 		$112K Buy
+19,084
New +$132K 0.01% 1028
2020
Q1 		– Sell
-14,350
Closed -$60K – 1234
2019
Q4 		$60K Sell
14,350
-4,425
-24% -$17K 0.01% 911
2019
Q3 		$57K Buy
+18,775
New +$58.1K 0.01% 893
2018
Q3 		– Sell
-17,113
Closed -$205K – 1208
2018
Q2 		$205K Buy
+17,113
New +$175K 0.03% 842
2018
Q1 		– Sell
-16,459
Closed -$163K – 1216
2017
Q4 		$163K Buy
+16,459
New +$171K 0.03% 898
2016
Q2 		– Sell
-25,232
Closed -$301K – 1033
2016
Q1 		$301K Buy
+25,232
New +$265K 0.08% 527

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dynamic Technology Lab's LXRX Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2024, closing a stake of 11,338 shares — an estimated $18K sold.

Dynamic Technology Lab first reported a position in LXRX in Q1 2016 and held it in 7 quarters. The position peaked at $301K in Q1 2016. 127 funds tracked by Wall St. Rank hold LXRX as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Lexicon Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 11,338 Lexicon Pharmaceuticals shares in Q4 2024, an estimated $18K.
  • Dynamic Technology Lab first reported a position in Lexicon Pharmaceuticals in Q1 2016 and held it in 7 quarters.
  • Dynamic Technology Lab's Lexicon Pharmaceuticals position peaked at $301K in Q1 2016.
  • 127 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.